PRAXPraxis Precision Medicines, Inc.
349.90USD+1.85%Mkt Cap: 9.77B USDP/E: Last update: 2026-05-26

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance i…

Indicators:|

Key Statistics

Company
Market Cap9.77B USD
Enterprise Value8.99B USD
Revenue (TTM)
Gross Profit-284.30M USD
Net Income (TTM)-303.27M USD
Revenue/Share
Last Price349.90 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees168
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-35.59
PEG
EV/EBITDA-25.16
EV/Revenue
P/S
P/B6.93
EPS (TTM)-13.39
EPS (Forward)-9.85
52W Range
35.2197% of range358.76
52W High358.76 USD
52W Low35.21 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-34.54%
ROA-32.33%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-249.07M USD
CapEx (TTM)56.00K USD
FCF Margin
FCF Yield-1.80%
Net Debt-785.43M USD
Net Debt/EBITDA2.20
Balance Sheet
Debt/Equity0.00
Current Ratio15.88
Quick Ratio15.66
Book Value/Sh50.61 USD
Cash/Share28.23 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:15
Split DateNov 29, 2023
Analyst Consensus
Rating1.5 (Strong Buy)
Target (Mean)652.18 USD
Target Range166.00 USD1245.00 USD
# Analysts17
Ownership
Shares Out.27.88M
Float24.01M
Insiders0.32%
Institutions115.83%
Short Interest
Short Ratio9.3d
Short % Float13.58%
Short % Out.13.55%
Shares Short3.78M
Short (prev mo.)3.95M
Technical
SMA 50321.45 (+8.8%)
SMA 200222.36 (+57.4%)
Beta2.78
S&P 52W Chg28.31%
Avg Vol (30d)395.69K
Avg Vol (10d)372.37K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)